Homburger provided legal services to Atlas Agro Holding on its latest investment deal, with Macquarie Asset Management committing up to USD 325 million in the company and its affiliated project entities through the Macquarie GIG Energy
Tags :Jasmin Künzle
Santhera Pharmaceuticals Holding has completed a 10:1 reverse split of its shares, which had been approved by the shareholders on June 27, 2023, with the listing and first day of trading of the post-split shares on the SIX
Homburger has provided legal counsel to Santhera Pharmaceuticals Holding (SIX: SANN “Santhera”) on its completion of a 10:1 reverse split of its shares. The reverse split, which was approved by shareholders on June 27, 2023, resulted in the
Santhera Pharmaceuticals Holding announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management to provide up to CHF 22.2 million in aggregate, subject to certain milestones
MCH Group, a renowed international live marketing company, has announced the result of its rights offering. The company will realise gross proceeds totalling CHF 76.9 million. MCH Group continues to have a stable, long-term anchor shareholder
Sandvik, a global high-tech engineering group headquartered in Sweden, has acquired Sphinx Tools, a Swiss based micro tools and surgical cutting tools producer. A coalition of investors led by Helvetica Capital, a Swiss-based private equity
Aris Gold Corporation has entered into a definitive agreement with MDC Industry Holding Company, a wholly owned subsidiary of the Abu Dhabi based investment company Mubadala Investment Company, whereby Aris Gold would acquire a 20% joint
Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
Kohlberg Kravis Roberts & Co (KKR), a global investment firm, and Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company, have entered into an agreement where KKR will acquire Biosynth Carbosynth
